Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adverse effects of beta-agonists.

The Journal of allergy and clinical immunology - 1 Dec 2002

Sears Malcolm R

Abstract excerpt

Short-acting beta-adrenergic receptor agonists have pharmacologically predictable dose-related and potency-related adverse effects, including tachycardia and tremor, and they also affect serum potassium and glucose. These effects all show tolerance with continued exposure. The potential for arrhy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Agonists
Share to Bronchodilator Agents
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Pharmaceutical Preparations

Source

Identifiers

PMID: 12464943
DOI: 10.1067/mai.2002.129966

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-12464943-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adverse effects of beta-agonists.PMID 12464943Read ↗

Safety and efficacy of beta agonists.Semantic proximity Read ↗

β2 Agonists.Semantic proximity Read ↗

Safety of long-acting beta-agonists in asthma: a review.Semantic proximity Read ↗

Benefit-risk assessment of long-acting beta2-agonists in asthma.Semantic proximity Read ↗

A comparison of the molecular pharmacological properties of current short, long and ultra-long-acting β2-agonists used for asthma and COPD.Semantic proximity Read ↗

Controversies regarding long-acting β2-agonists.Semantic proximity Read ↗

Pharmacogenetics of beta2 adrenergic receptor agonists in asthma managementSemantic proximity Read ↗

Pharmacogenetics of β2-AgonistsSemantic proximity Read ↗

The beta-2 adrenergic receptor and its agonists.Semantic proximity Read ↗

beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications.Semantic proximity Read ↗

Pharmacogenomics for the efficacy and side effects of antihistaminesSemantic proximity Read ↗

Correlation of inhaled long-acting bronchodilators with cardiovascular adverse events in COPD patients: A real-world analysis of post-marketing surveillance dataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.